Purpose: To assess the feasibility of high-dose-rate perioperative multicatheter interstitial brachytherapy to deliver accelerated partial breast irradiation (APBI) in selected patients with early breast cancer.

Methods And Materials: Perioperative multicatheter interstitial brachytherapy for APBI has been used at our department since 2012 for patients with low-risk breast cancer. Interstitial catheters were inserted perioperatively via hollow needles immediately following tumorectomy with sentinel node biopsy. APBI started on Day 6 after surgery. The prescribed dose was 34 Gy (10 fractions of 3.4 Gy bid). Hormonal therapy was prescribed in all cases.

Results: Between June 2012 and December 2017, 125 patients were scheduled for APBI. Of these, APBI was not performed in 12 patients (9.6%) due to adverse prognostic factors identified on the definitive biopsy. We observed wound dehiscence in 2/113 cases (1.8%), inflammatory complications requiring antibiotics in 7/113 cases (6.2%), transient Grade I radiodermatitis in 6/113 patients (4.4%), and seroma which resolved spontaneously in 3/113 patients (2.7%). With median followup of 39 months (range 3.3-75.3) no relapses were observed. No late complications in Radiation Therapy Oncology Group Grade 3 or higher were documented. Cosmetic outcome in patients with followup > 2 years was excellent or good in 92%.

Conclusion: Our preliminary results show that the perioperative multicatheter interstitial high-dose-rate brachytherapy for APBI in selected patients with early breast cancer is feasible. This treatment schedule reduces treatment duration, spares the patients of repeated anesthesia, and enables precise application of the afterloading tubes under direct visual control.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2018.08.012DOI Listing

Publication Analysis

Top Keywords

perioperative multicatheter
16
multicatheter interstitial
16
patients
9
accelerated partial
8
partial breast
8
breast irradiation
8
interstitial brachytherapy
8
apbi selected
8
selected patients
8
patients early
8

Similar Publications

Although the coexistence of cervical and lumbar spinal conditions is fairly common, surgical treatments are usually staged, even though simultaneous fusion of the cervical and lumbar spine may be a viable option for appropriate candidates. We sought to investigate the outcomes of staged vs simultaneous cervical and lumbar fusions in terms of differences in postoperative complications and resource use. We performed a retrospective cohort study using claims data from the 2006 to 2020 all-payer Premier Health Database.

View Article and Find Full Text PDF

Multimodal Analgesia and Outcomes in Hysterectomy Surgery-A Population-Based Analysis.

J Clin Med

September 2024

Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Muellner Hauptstrasse 48, 5020 Salzburg, Austria.

Article Synopsis
  • A study analyzed data from over 1.3 million hysterectomies from 2006 to 2022 to assess the effects of multimodal analgesia on postoperative complications and opioid prescriptions.* -
  • Results showed that 84.3% of patients received multimodal analgesia, which significantly lowered the odds of complications, reduced opioid prescriptions, and shortened hospital stays.* -
  • Findings highlight the effectiveness of combining opioids with non-opioid pain relievers, leading to fewer serious complications, less opioid use, and lower healthcare costs.*
View Article and Find Full Text PDF
Article Synopsis
  • The study compares the effectiveness of very accelerated partial breast irradiation (VAPBI) using 3-4 fractions to standard treatment requiring 7-8 fractions over 4-5 days for breast cancer patients.
  • A total of 81 patients participated, with findings showing a low breast recurrence rate of 3.4% and manageable side effects like pigmentation changes and mild fibrosis.
  • The conclusion suggests that VAPBI offers good local control similar to traditional methods but in a shorter timeframe, benefiting both patients and healthcare providers.
View Article and Find Full Text PDF
Article Synopsis
  • A study reviewed the impact of neuraxial anesthesia versus general anesthesia on outcomes for patients undergoing total hip/knee arthroplasty (THA/TKA) over a period from 2006 to 2021, as practices and usage shifted towards neuraxial.
  • Data from the Premier Healthcare Database showed increased use of neuraxial anesthesia and demonstrated lower rates of adverse outcomes, like renal failure and need for blood transfusions, particularly from 2016 to 2021 compared to 2006 to 2015.
  • The results reaffirmed earlier findings, highlighting the lasting advantages of using neuraxial anesthesia in orthopedic surgeries.
View Article and Find Full Text PDF

Background And Purpose: Multicatheter breast brachytherapy is a standard technique for accelerated partial breast irradiation (APBI) in early breast cancer patients. Intraoperative multicatheter breast implant (IOMBI) followed by perioperative high-dose-rate brachytherapy (PHDRBT) offers a novel and advantageous approach. We present long-term oncological, toxicity, and cosmesis outcomes for a well-experienced single institution.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!